Format

Send to

Choose Destination
Am J Otolaryngol. 2015 Jan 22. pii: S0196-0709(15)00033-2. doi: 10.1016/j.amjoto.2015.01.013. [Epub ahead of print]

WITHDRAWN: Improved therapeutic effectiveness by combining recombinant p14ARF with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma.

Author information

1
Department of Otorhinolaryngology, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
2
Department of Otorhinolaryngology, State Key Laboratory of Biotherapy, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China. Electronic address: fxjming@163.com.
3
Department of Otorhinolaryngology, the Second Affiliated Hospital of Kunming Medical College, Kunming, 650101, People's Republic of China.

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center